Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug.
Pan D, Sanyal N, Schmieder AH, Senpan A, Kim B, Yang X, Hu G, Allen JS, Gross RW, Wickline SA, Lanza GM.
Pan D, et al.
Nanomedicine (Lond). 2012 Oct;7(10):1507-19. doi: 10.2217/nnm.12.27. Epub 2012 Jun 18.
Nanomedicine (Lond). 2012.
PMID: 22709347
Free PMC article.